Introduction
Introduction Statistics Contact Development Disclaimer Help
Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
MS Speaks
*****************************************************
(ECTRIMS) Ocrelizumab may double serious infection risk in MS
0 replies
(ACTRIMS abst.) MS patients treated with ocrelizumab, aged 70 ...
1 replies
Genentech updates Phase 3 Ocrevus high-dose study in people w/...
0 replies
Ocrevus biosimilar (Xacrel) shows equivalent efficacy as MS tr...
0 replies
(Nature) Ocrelizumab biosimilar Xacrel compared to Ocrevus...
0 replies
(Abst.) The wearing-off phenomenon of ocrelizumab in patients ...
1 replies
(Abst.) Recurrence of disease activity after ocrelizumab disco...
0 replies
Subcutaneous Ocrevus Zunovo has FDA approval
0 replies
(Abst.) Ocrelizumab in people w/primary progressive MS...
0 replies
Subcutaneous Ocrevus gets EU approval
1 replies
*****************************************************
Next Page
You are viewing proxied material from gopher.createaforum.com. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.